Pharmaron at Phacilitate’s Advanced Therapies Week 2025
Capabilities
Pharmaron was proud to participate in Phacilitate Advanced Therapies Week 2025, hosted by Phacilitate from January 20-23, 2025, at the Kay Bailey Hutchison Convention Center in Dallas, TX. This premier industry event brought together global leaders in cell and gene therapy (CGT) to discuss advancements, regulatory challenges, and the future of CGT commercialization.
Advanced Therapies Week fosters collaboration across the biotech, pharmaceutical, and manufacturing sectors. It offers a platform for companies to share expertise, explore new technologies, and drive innovation in advanced therapies. The conference featured various scientific sessions, panel discussions, and networking opportunities, with topics ranging from regulatory strategies and clinical trial design to manufacturing scalability and analytical development.
At booth #675, Pharmaron’s team engaged with industry experts and showcased our comprehensive CGT and bioanalytical capabilities, designed to support programs at every stage—from discovery through commercialization. Our integrated services include:
- Preclinical Services – Efficacy studies, pharmacokinetics, tumorigenicity, toxicology, bioanalysis for biodistribution and viral shedding, and immunogenicity assays.
- Clinical Services – Non-GLP and GLP bioanalytical assays, immunogenicity testing, and biomarker development and validation.
- CMC/Manufacturing – Scalable suspension chromatography, plasmid, AAV process development, proprietary plasmid design, HEK cell line expertise, GMP and non-GMP cell banking, plasmid manufacturing, and IND-enabling capabilities.
- Analytical Testing – Full-service protein and viral analytics, product characterization, potency assay development, validation, and QC release testing.
The conference provided valuable discussions on the evolving landscape of CGT development and commercialization, reinforcing the importance of end-to-end solutions that streamline development pathways. As the industry continues to advance, Pharmaron remains committed to providing innovative, efficient, and regulatory-ready solutions that help bring transformative therapies to patients worldwide.
CGT Webinar Series
